Broad-Spectrum Micronutrients or Antidepressants for Antenatal Depression: Effect on Maternal and Infant Birth Outcomes in an Observational Secondary Analysis of NUTRIMUM
One-fifth of women experience antenatal depression. Untreated antenatal depression is associated with increased risk of adverse birth outcomes. This study investigated the effect of broad-spectrum micronutrients (BSM; vitamins and minerals), used to treat antenatal depression (NUTRIMUM trial), on birth outcomes.
Efficacy and Safety of Dose Increase From 40 mg/d to 80 mg/d of Lurasidone in Patients With Schizophrenia: A Post Hoc Analysis of Extension Trial
The primary objective of this study was to evaluate the efficacy and safety of increasing the dose of lurasidone from 40 mg/d to 80 mg/d in patients with schizophrenia.
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset
Somatic symptoms are commonly seen in major depressive disorder (MDD) with postpartum onset and can be similar to side effects of antidepressant medications. The aim of this study is to determine whether the decline in depressive symptoms measured by the Structured Interview Guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS) is significantly associated with the decrease in somatic symptoms identified by the Asberg scale.
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia: The Role of Pseudoephedrine
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications
Ethics in Psychedelic Science: Promises and Responsibilities
Recurrent Pancreatitis Associated With Atomoxetine Use in a 9-Year-Old Boy: A Case Report
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty
The aim of this study was to examine the effect of fluoxetine and sertraline on height growth and insulin-like growth factor-1 (IGF-1) during puberty.
Antipsychotic Polypharmacy in Time Course: Evidence for a Cross-titration Trap
Antipsychotic polypharmacy (APP) is controversial yet applied in 20% of patients with psychotic disorders. We investigated indications for initiating and continuing APP, including the contribution of unfinished cross-titrations.
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer: A Case Report and Literature Review
Bipolar Disorder in a Young Adult With Thalassemia Major With Sequential Development of Neuroleptic Malignant Syndrome and Serotonin Syndrome
Question: Do You Have Suggestions for Managing a Patient With Bipolar II Disorder, Binge Eating Disorder, and Obesity Who Stops Medications Fearing Weight Gain?
Myocarditis on Clozapine 50 mg/d in a Patient With Parkinson's Disease
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use: A Case Report
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report
Ketamine. The Story of Modern Psychiatry's Most Fascinating Molecule
Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting-A Case Report
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine: A Case Report
